SEC Wins Insider Trading Trial Of Ex-InterMune Director
A California federal jury found Monday that a former InterMune director tipped off a friend about the pending European approval of the pharmaceutical maker's lung disease drug, handing the U.S. Securities...To view the full article, register now.
Already a subscriber? Click here to view full article